Credit: Shutterstock photoAmong the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in BlackRock Inc (Symbol: BLK), where a total of 5,347 contracts have traded so far, representing approximately 534,700 underlying shares. That amounts to about 123.9% of BLK's average daily trading volume over the past month of 431,410 shares. Especially high volume was seen for the $570 strike call option expiring February 16, 2018 , with 386 contracts trading so far today, representing approximately 38,600 underlying shares of BLK. Below is a chart showing BLK's trailing twelve month trading history, with the $570 strike highlighted in orange:
Esperion Therapeutics Inc (Symbol: ESPR) options are showing a volume of 6,061 contracts thus far today. That number of contracts represents approximately 606,100 underlying shares, working out to a sizeable 114.2% of ESPR's average daily trading volume over the past month, of 530,925 shares. Especially high volume was seen for the $55 strike put option expiring February 16, 2018 , with 1,531 contracts trading so far today, representing approximately 153,100 underlying shares of ESPR. Below is a chart showing ESPR's trailing twelve month trading history, with the $55 strike highlighted in orange:
And Caesars Entertainment Corp (Symbol: CZR) saw options trading volume of 92,053 contracts, representing approximately 9.2 million underlying shares or approximately 108.2% of CZR's average daily trading volume over the past month, of 8.5 million shares. Particularly high volume was seen for the $11 strike call option expiring January 19, 2018 , with 45,655 contracts trading so far today, representing approximately 4.6 million underlying shares of CZR. Below is a chart showing CZR's trailing twelve month trading history, with the $11 strike highlighted in orange:
For the various different available expirations for BLK options , ESPR options , or CZR options , visit StockOptionsChannel.com.
Today's Most Active Call & Put Options of the S&P 500 »
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
